About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
4 01, 2026

XRP News Today: Senate Crypto Bill Puts $3 XRP Forecast in Play

By |2026-01-04T11:22:43+02:00January 4, 2026|Crypto News, News|0 Comments

XRPUSD – Daily Chart – 040126 – Market Structure Bill

The price action underscored XRP’s sensitivity to crypto-related regulatory developments on Capitol Hill, driven by the resolution of the SEC vs. Ripple case.

The US Court of Appeals approved Ripple and the SEC’s appeal withdrawal motions on August 22. The court ruling legitimized XRP as a non-security, paving the way to the US XRP-spot ETF market.

XRP Bullish Outlook Intact

XRP-spot ETF flow trends and crypto-related legislative developments reaffirmed the bullish short-term (1-4 weeks) outlook, with a $2.5 price target. Meanwhile, increased utility, expectations of Fed rate cuts, and the Senate passing the Market Structure Bill reinforce the positive longer-term price trajectories:

  • Medium-term (4-8 weeks): $3.0.
  • Longer-term (8-12 weeks) $3.66.

Key Risks Challenge Bullish Outlook

Several scenarios could unravel the positive outlook. These include:

  • The Bank of Japan declares a neutral interest rate of between 1.5% and 2.5%, signaling aggressive rate hikes. A higher neutral rate may trigger a yen carry trade unwind, which would weigh on risk assets.
  • US economic data and the Fed are cooling expectations of a March rate cut.
  • The MSCI delists digital asset treasury companies (DATs). Delistings are likely to temper interest in XRP as a treasury reserve asset.
  • Partisan opposition to the Market Structure Bill.
  • XRP-spot ETFs report outflows.

These scenarios would likely push the token toward $1.75, indicating a bearish trend reversal.

Technical Indicators Continue to Signal Caution

XRP gained 0.60% on Saturday, January 3, consolidating the previous day’s 6.76% rally, closing at $2.0184. The token mirrored the broader crypto market cap, which advanced 0.71%.

Despite heading for a four-day winning streak, XRP traded below the 50-day and 200-day Exponential Moving Averages (EMAs), suggesting a bearish bias. While technicals remained bearish, bullish fundamentals are building, countering the technical structure.

Key technical levels to watch include:

  • Support levels: $2.0, $1.75, and then $1.50.
  • 50-day EMA resistance: $2.0404.
  • 200-day EMA resistance: $2.3472.
  • Resistance levels: $2.5, $3.0, and $3.66.

Looking at the daily chart, a breakout above the 50-day EMA would indicate a near-term bullish trend reversal. A sustained move through the 50-day EMA would bring the 200-day EMA and the $2.5 resistance level into play.

A breakout above the EMAs would reinforce the bullish medium-term outlook and the longer-term (8-12 weeks) $3.66 price target.

Source link

4 01, 2026

Manufacturing the future of health: Opportunities in dietary supplements

By |2026-01-04T09:30:31+02:00January 4, 2026|Dietary Supplements News, News|0 Comments


The dietary supplement industry is at a pivotal moment. As people place greater emphasis on proactive health, prevention, and daily wellness, dietary supplements have become an essential part of how individuals support their bodies and overall quality of life. Behind every trusted supplement is one critical foundation: responsible, high-quality manufacturing. 

Consumers today are more health-conscious than ever. Rather than waiting for illness, people are seeking ways to support energy, recovery, immune function, longevity, and overall well-being through informed nutrition and supplementation. This shift has driven rapid growth across the dietary supplement sector, spanning both human and pet health. 

As demand increases, so does the need for supplements that are safe, effective, and thoughtfully formulated. Manufacturing plays a defining role in ensuring products truly support health rather than simply meeting market trends. 

The growth of the dietary supplement industry presents significant opportunities within manufacturing — particularly in innovation. Modern supplement manufacturing is where science, technology, and quality systems converge to turn health-focused ideas into reliable products. 

Innovation in manufacturing enables: 

· Science-informed, accurately dosed supplements consumers can trust 

· Improved manufacturing technologies that enhance consistency, safety, and scalability 

· Formulation advancements that support bioavailability and functional delivery 

· Adaptation to evolving regulatory and quality expectations 

· Infrastructure that supports responsible growth and global distribution 

When innovation is integrated into manufacturing, it strengthens the entire supplement industry and protects the people who rely on these products for their health. 

Montana Global Health, based in Kalispell, is a contract manufacturer of dietary supplements for both human and pet health. We work with clients across the United States and around the world, manufacturing products that are shipped globally while maintaining consistent standards for quality, documentation, and compliance. 

Our role is to support brands committed to proactive wellness, transparency, and integrity. From ingredient sourcing and formulation support to scale-up and final production, every decision impacts consumer trust and long-term outcomes. 

As individuals continue to prioritize their health, dietary supplements will remain an important tool in preventive and supportive care. The future of the industry will be shaped by manufacturers who embrace innovation, accountability, and higher standards. 

Manufacturing opportunities in dietary supplements extend beyond growth alone. They represent a chance to improve health outcomes, support informed consumer choices, and build an industry grounded in quality and integrity. 

Terri Chichester is the founder of Montana Global Health, a contract manufacturer of human and pet dietary supplements based in Kalispell



Source link

4 01, 2026

Is This DOGE Rally Just The Start Of What’s To Come?

By |2026-01-04T09:21:32+02:00January 4, 2026|Crypto News, News|0 Comments

With Dogecoin investors now seeking to increase their exposure to lower-priced utility-backed solutions, has emerged as the top alternative. Instead of relying on price speculation, Remittix is focused on becoming a crypto-to-fiat payments hub for users, merchants, and businesses worldwide. The Ethereum-based PayFi solution is solving the $19 trillion problem of cross-border payments.

Already, Remittix has been able to secure over $28.6 million in private funding from investors, a clear demonstration of its appeal and adoption success. Building on this, Remittix has also released its new wallet on the App Store. This marks its first major product release. 

The PayFi solution is also enjoying strong retail attention. At the moment, Remittix is running a , with only 5 million tokens allocated. Already, 25% of the allocated volume has been swept up in the last 24 hours. This reflects accelerating interest as investors position early ahead of the PayFi launch. The team has confirmed that its crypto-to-fiat PayFi platform will .

Here are some other reasons investors are excited about Remittix:

  • Multiple top-tier crypto exchanges like BitMart and LBANK already confirmed

  • Clear payment-focused utility rather than speculative narratives

  • Strong product execution with wallet already live on App Store

  • Successful

Dogecoin price may continue to see bursts of momentum as traders rotate back into meme coins. This means that for short-term market moves, DOGE remains relevant. However, when looking toward 2026, projects with real infrastructure and clear delivery timelines, like Remittix, are drawing more serious attention.

Source link

4 01, 2026

Sui Taipei Builders’ Demo Day Set for Jan 4 2026

By |2026-01-04T08:18:20+02:00January 4, 2026|News, NFT News|0 Comments


Sui Taipei Builders’ Demo Day brings developers, investors, and enthusiasts together to present blockchain projects.

The Sui ecosystem will host the Taipei Builders’ Demo Day at National Taiwan University on 4th January 2026. It will showcase innovative DeFi and Web3 projects. Developers from the Sui community will present their applications to judges and attendees. 

Scallop founder DJ Chris, Harrison Kim, and Ivan Tok will evaluate the projects. The event aims to connect builders, investors, and enthusiasts while supporting Sui ecosystem growth.

Sui Demo Day Judges and Event Details

The Demo Day judging panel includes DJ Chris, Harrison Kim, and Ivan Tok. They will assess projects based on originality, technical quality, and user experience. Attendees can view live demonstrations of Sui-native applications and interact directly with builders. 

Organizers expect the event to highlight innovative smart contracts, DEX integrations, and DeFi solutions. Builders will also receive feedback from judges to improve their projects.

The event will include networking sessions for developers and investors. Participants can ask questions and explore potential partnerships. Scallop’s involvement aims to strengthen community connections and the adoption of Sui tools. 

Builders will gain visibility within the ecosystem and access potential funding opportunities. The event is designed to support collaboration among emerging Sui developers.

Sui Ecosystem Shows Strong Market Activity

The Demo Day comes as Sui trading activity grows across exchanges. Decentralized exchange volumes recently reached $408 million in 24 hours. Daily perpetual futures trading on Sui also approached $197 million, signaling growing user engagement. 

Vandit Grover noted that these metrics show both speculative and on-chain participation increasing steadily. Institutions like Crypto.com and Fireblocks have launched Sui custody and liquidity services.

Ecosystem growth continues with more validators and improved network throughput. Protocol teams introduced trading incentives and liquidity programs to support adoption. Wallet integrations and smoother user interfaces are increasing accessibility for new users. 

Builders attending the Demo Day will benefit from a thriving environment for testing and launching applications. Rising liquidity also helps attract long-term participants to Sui projects.

Opportunities for Builders at Sui Taipei

The Demo Day provides builders the chance to showcase new applications to investors and the community. Workshops and live demonstrations will expose participants to emerging Sui tools and protocols. 

Essentially, networking sessions will allow builders to form collaborations and explore funding opportunities. Attendees can gain insights into market trends, DeFi adoption, and Web3 project development. Organizers emphasize that developers of all levels are welcome to participate.

Participants will learn practical applications for smart contracts, DEX integrations, and other Sui services. The event highlights the ecosystem’s growth, supporting both innovation and adoption. Builders can present projects, receive expert feedback, and connect with institutions active in Sui. 

Related Readings: Sui News: SUI Attracts $1.8 Billion in Stablecoin Inflows

Scallop’s judging and mentorship will encourage high-quality project development. The Demo Day is expected to foster long-term collaboration and innovation within the Sui ecosystem.

The Sui Taipei Builders’ Demo Day demonstrates the ecosystem’s focus on innovation, adoption, and developer support. The event allows builders to showcase projects, meet key figures, and explore collaboration opportunities. 

With strong participation from judges, developers, and institutions, the Demo Day represents a key milestone in the Sui DeFi and Web3 ecosystem.





Source link

4 01, 2026

Silver (XAG) Forecast: Silver Analysis Shows Reversal Top Targets $64.79-$60.25

By |2026-01-04T08:10:00+02:00January 4, 2026|Forex News, News|0 Comments


Scan QR code to install app

Important DisclaimersFXEmpire is owned and operated by Empire Media Network LTD., Company Registration Number 514641786, registered at 7 Jabotinsky Road, Ramat Gan 5252007, Israel. The content provided on this website includes general news and publications, our personal analysis and opinions, and materials provided by third parties. This content is intended for educational and research purposes only. It does not constitute, and should not be interpreted as, a recommendation or advice to take any action, including making any investment or purchasing any product. Before making any financial decision, you should conduct your own due diligence, exercise your own discretion, and consult with competent advisors. The content on this website is not personally directed to you, and we do not take into account your individual financial situation or needs. The information contained on this website is not necessarily provided in real time, nor is it guaranteed to be accurate. Prices displayed may be provided by market makers and not by exchanges. Any trading or other financial decision you make is entirely your own responsibility, and you must not rely solely on any information provided through the website. FXEmpire does not provide any warranty regarding the accuracy, completeness, or reliability of any information contained on the website and shall bear no responsibility for any trading losses you may incur as a result of using such information. The website may include advertisements and other promotional content. FXEmpire may receive compensation from third parties in connection with such content. FXEmpire does not endorse, recommend, or assume responsibility for the use of any third-party services or websites. Empire Media Network LTD., its employees, officers, subsidiaries, and affiliates shall not be liable for any loss or damage resulting from your use of the website or reliance on the information provided herein.Risk DisclaimersThis website contains information about cryptocurrencies, contracts for difference (CFDs), and other financial instruments, as well as about brokers, exchanges, and other entities trading in such instruments. Both cryptocurrencies and CFDs are complex instruments and involve a high risk of losing money. You should carefully consider whether you understand how these instruments work and whether you can afford to take the high risk of losing your money. FX Empire encourages you to conduct your own research before making any investment decision and to avoid investing in any financial instrument unless you fully understand how it works and the risks involved.



Source link

4 01, 2026

Quiet Strength, Cautious Optimism Behind Japan’s Tea Champion

By |2026-01-04T07:29:20+02:00January 4, 2026|Dietary Supplements News, News|0 Comments


Ito En’s share price has drifted modestly higher over the past week while holding a solid year?on?year gain. Behind the calm chart is a company quietly refining its green tea dominance, defending margins against cost pressures and drawing measured interest from analysts who see limited downside but only selective upside.

Investors hunting for fireworks in Japanese consumer stocks will not find a spectacle in Ito En right now, but the market’s message is quietly constructive. The tea and beverage specialist has edged up over the past several sessions, extending a steady medium term advance while avoiding the sharp swings seen elsewhere in the food and drink space. The tone around the stock is neither euphoric nor fearful. Instead, Ito En sits in that intriguing middle ground where resilient fundamentals and modest valuation upside coexist with very real margin and FX risks.

One-Year Investment Performance

A year ago, buying Ito En looked like a conservative bet on Japanese consumption rather than a high octane growth play. That caution has been rewarded more than punished. Based on exchange data compiled from Yahoo Finance and other quote services, Ito En’s stock closed roughly 15 to 20 percent lower one year ago compared with its latest close. The exact figures vary slightly across providers, but the directional message is clear: the past twelve months have delivered a solid, mid teens percentage gain for patient shareholders.

What does that mean in real money terms? A hypothetical investor who had committed the equivalent of 10,000 units of local currency to Ito En a year ago would now sit on a position worth roughly 11,500 to 12,000, before dividends and trading costs. That is not the kind of windfall that turns heads on social media, yet in the context of a choppy global consumer landscape and lingering inflation in input costs, it reflects impressive capital preservation with a respectable kicker. The ride has not been entirely smooth, with pullbacks during broader Japanese equity corrections, but the long term trajectory still tilts decisively upward.

For investors who stepped in near last year’s lows, the performance looks even better when viewed against Ito En’s 52 week range. The share price currently trades close to the upper half of that band, comfortably above the 52 week low and below but not far from the 52 week high. That position within the range suggests that while the easy money from the recovery phase may already be made, the stock has avoided the kind of frothy overextension that often precedes sharp reversals.

Recent Catalysts and News

In terms of fresh headlines, the past several days have been relatively subdued for Ito En. A targeted search across major business outlets and Japanese market coverage turns up no blockbuster announcements such as transformative acquisitions or radical management changes in the very recent past. Instead, the narrative revolves around incremental developments: ongoing product refreshes in the ready to drink green tea segment, marketing efforts around functional beverages and continued discipline in cost management amid elevated raw material and logistics expenses.

Earlier this week, local coverage and industry commentary focused more on sector level trends than on Ito En specifically. Rising attention to healthier, low sugar drinks and sustained interest in green tea based beverages continues to favor Ito En’s core franchise. The company appears to be leaning into this tailwind with product line extensions and packaging innovations rather than radical repositioning. At the same time, commentary from Japanese equity strategists highlights that food and beverage names such as Ito En are benefiting from investors rotating toward defensive growth while keeping a close eye on yen fluctuations that can affect imported ingredient costs.

Looking slightly beyond the very latest headlines and into the recent quarter, Ito En’s results have generally reinforced this picture of measured momentum. Revenue growth has been supported by both volume and pricing, though management has acknowledged that passing through higher costs without denting demand remains a delicate balancing act. There has been no sign of a dramatic pivot away from the core tea and beverage business, which remains the economic engine, but rather a continued emphasis on deepening distribution, optimizing vending machine networks and fine tuning the product mix for profitability.

Wall Street Verdict & Price Targets

When it comes to external opinions, Ito En does not command the same level of global analyst coverage as mega cap tech or automotive names, yet several major houses keep the stock on their radar. A search across international broker commentary from providers such as Morgan Stanley, UBS and local Japanese brokerages indicates a broadly neutral to moderately positive stance within the last month. The prevailing rating cluster sits around Hold with select Buy recommendations that frame Ito En as a quality defensive play rather than a high growth story.

Recent notes from analysts, as summarized in regional financial media, point to price targets that imply limited but not negligible upside from the current quote. Typical target ranges hover in the mid single digit to low double digit percentage above the latest trading level. Morgan Stanley and UBS, for example, emphasize Ito En’s strong brand equity and stable cash generation, but temper their enthusiasm with references to cost inflation, domestic market saturation and the relatively slow pace of overseas expansion. There is little appetite to slap a Sell label on the stock, yet these institutions also stop short of championing it as a must own outperformer.

This consensus leaves investors with a clear message. At current prices, Wall Street and Tokyo based strategists broadly regard Ito En as fairly valued to slightly undervalued. The stock’s 90 day trend, which shows a gentle upward slope rather than a sharp spike, reinforces this notion of gradual appreciation rather than speculative frenzy. For portfolio builders, that makes Ito En a candidate for the core defensive sleeve more than a tactical trading vehicle.

Future Prospects and Strategy

Underneath the share price sits a business model that is remarkably simple to describe yet difficult to replicate. Ito En is, at its heart, a beverages company built on Japanese tea culture. It has turned green tea and related drinks into a scalable, highly recognizable product family across supermarkets, convenience stores and vending machines. The company also extends into tea leaves and allied products, but the ready to drink segment is the centerpiece of both revenue and investor attention.

Looking ahead to the coming months, several factors will shape Ito En’s trajectory. First, input cost dynamics matter. Any easing in packaging and logistics expenses would flow quickly into margins, especially if the company can hold the pricing gains it has already pushed through. Second, currency moves remain a double edged sword, influencing both imported costs and the translation of any overseas earnings. Third, domestic demand for healthier beverages provides a structural tailwind, but the pace and profitability of international expansion will determine whether Ito En can accelerate growth beyond its home market baseline.

The technical picture complements this fundamental story. The five day performance shows a modest gain, reflecting gentle buying interest rather than a speculative surge, while the broader 90 day trend captures a slow grind higher from previous consolidation levels. Volatility has been contained, suggesting that short term traders are not dominating the shareholder register. If the company can deliver another stable earnings print and demonstrate continued discipline on costs, the stock appears well placed to continue this steady ascent, albeit without dramatic re rating.

For investors, the key question is simple: is a high quality, defensive Japanese beverage champion with mid teens one year gains and a calm chart worth holding at current levels? The answer likely depends on portfolio context. For those seeking explosive growth, Ito En may look too measured. For those seeking resilient cash flows, brand strength and a relatively predictable earnings stream in a turbulent world, the market’s current, cautiously bullish stance on Ito En might feel exactly right.



Source link

4 01, 2026

4 Supplements You Shouldn’t Take for Weight Loss

By |2026-01-04T05:28:17+02:00January 4, 2026|Dietary Supplements News, News|0 Comments


  • Some supplements for weight loss are unregulated, may be harmful and are not recommended.
  • Do not take green coffee bean extract, Garcinia cambogia, raspberry ketone or caffeine.
  • Work toward an energy deficit for weight loss with a healthy diet and daily exercise.

Losing weight is challenging, and many people turn to weight-loss supplements to help achieve their goals. Unfortunately, many supplements marketed for weight loss don’t do what they promise—and may even work against your goals. Not only are supplements expensive, but they are also unregulated, so you don’t always know what you’re getting. The best way to lose weight is to focus on a food-first approach, which means eating plenty of nutrient-dense foods and maintaining a slight calorie deficit over time. 

In this article, we get into some popular weight-loss supplements and why nutrition professionals don’t recommend them, plus helpful tips for healthy, sustainable weight loss. Knowing what to watch out for can help you make informed choices and prioritize strategies that actually support your health and weight-loss journey.

Green Coffee Bean Extract

If you’ve searched for supplements aiding weight loss, you’ve likely come across green coffee bean extract. Quite simply, this supplement is derived from the coffee plant’s seeds, which are green before roasting. “[Green coffee bean extract] has chlorogenic acid, a coffee compound that can supposedly decrease fat absorption and speed up metabolism,” says Danielle VenHuizen, M.S., RDN. She adds that these claims are mostly unwarranted. 

Only a few human trials have examined the effectiveness of green coffee bean extract on weight loss. These trials had poor study design and showed mixed results. While one study found that green coffee extract may help reduce weight and body mass index, there wasn’t a significant effect on body fat percentage, meaning that the mass lost could come from water or muscle.

Body mass index (BMI) is a flawed measure that’s often used in healthcare to determine a person’s body weight category, and therefore, chronic disease risk. However, it has limitations and does not account for individual factors that influence one’s health status, such as body composition, ethnicity, race, sex and age. This is why it shouldn’t be used as a comprehensive measure of someone’s health and can be a source of body size stigma and bias.

“Additionally, in my clinical experience, I have yet to meet a client who has lost weight by using green coffee bean extract,” says VenHuizen. Lastly, there isn’t much information on the safety of green coffee bean extract, so buyers beware. 

Garcinia Cambogia

Garcinia cambogia is a fruit with ​​hydroxycitric acid (HCA), a compound thought to reduce fat production in the body and suppress appetite. “Studies seem to indicate that some of these claims might be true, but unfortunately, the benefits are modest, and the research is conflicting,” says VenHuizen. One study states that there are only a small number of studies on Garcinia cambogia, and the methodology is poor, meaning that these results shouldn’t be trusted.

Even more alarming, “several studies have reported liver issues with long-term use of this supplement,” says VenHuizen. This is another pretty convincing reason to avoid adding this supplement to your weight-loss regimen. 

Raspberry Ketone

Raspberry ketone is a compound found in the raspberry fruit. Small test-tube and animal studies suggest it may suppress the buildup of fat in the body, but the results are extremely limited. There has only been one human study on the effects of raspberry ketone on weight loss. The participants took the supplement for eight weeks while also following a calorie-restricted diet. The raspberry ketone supplement was combined with caffeine, bitter orange, ginger, garlic, cayenne, L-theanine, pepper extract, B vitamins and chromium. 

The 45 participants who finished the study lost weight, but it’s impossible to know if it was due to the raspberry ketone blend or the calorie deficit. In short, there isn’t enough evidence to support raspberry ketone for weight loss, so save your money. Instead, we recommend snacking on some raspberries, which have several health benefits, including filling fiber and inflammation-fighting anthocyanins.

Caffeine

The most recognizable supplement on this list, caffeine is a compound that stimulates the nervous system. It’s naturally present in tea, coffee and chocolate, as well as in herbal supplements like guarana. Caffeine increases thermogenesis, the body’s natural production of heat. During this process, the body burns extra calories. 

Research suggests caffeine can help with weight loss, but a large dose is necessary to create a response. One study concluded that more than 3 milligrams of caffeine per kilogram of body weight is necessary to stimulate the breakdown of fat. For a 150-pound person, that’s 200 mg of caffeine, or two cups of coffee. 

It is recommended to cap caffeine consumption 400 mg daily for safety, but everyone has a different tolerance level. People sensitive to caffeine may experience symptoms like nervousness, jitters, heart racing and headaches, among others. 

Although caffeine may increase fat loss, it’s not the best way to lose weight, especially because supplements with caffeine may contain more than that, plus other stimulants. That said, caffeine from natural sources like coffee is the safest way to consume caffeine. So, feel free to include a cup of coffee or tea in your day for an energy boost, but don’t expect it to affect your weight too much. 

Tips for Healthy Weight Loss 

Although they may not be quick or flashy, the most effective tools for losing weight are good old-fashioned healthy eating and exercise. VenHuizen recommends increasing fiber-rich fruits and vegetables and healthy fats in the diet. “These foods naturally increase satiety and provide anti-inflammatory benefits that may aid in weight loss,” says VenHuizen. “And unlike supplements, studies on fruit and vegetable intake show that these foods improve weight-loss efforts,” she adds. 

In addition, “Trying to stay moderately active throughout the day, especially for people who work sedentary desk jobs, can help with weight loss,” says Madeleine Putzi, M.S., RDN. She recommends getting up and walking around once per hour to increase your total amount of steps for the day, which is an easy and non-taxing way to increase your daily calorie burn. 

Putzi also suggests investing in a standing desk and/or a walking pad if possible. “If you walk for 10 minutes at 3 miles per hour, you will hit around 1,000 steps. Do that every hour, and that’s an easy 8,000 steps by the end of your workday,” says Putzi.

Our Expert Take

Weight-loss supplements are usually not worth the expensive price tag. If a supplement promises to “magically burn fat or flatten your belly,” chances are it’s not the miracle that’s promised on the bottle. A food and exercise approach to weight loss is the most effective way to reach your weight-loss goals in a sustainable way.



Source link

4 01, 2026

Cardano Price Prediction: ADA Faces Trendline Rejection Near $0.35 as Bearish Momentum Builds

By |2026-01-04T05:19:38+02:00January 4, 2026|Crypto News, News|0 Comments

Cardano price is struggling below $0.35 trendline resistance as bearish momentum persists, with traders watching the $0.30–$0.35 support zone for signs of a potential base or further downside.

Cardano price is back under pressure as the price continues to stall below the descending trendline resistance near $0.35. Despite several short-lived bounces, buyers have yet to show conviction, leaving the near-term structure skewed to the downside.

This hesitation comes as ADA trades near the lower end of its multi-month range following a prolonged drawdown from its 2021 high. While longer-term support levels are beginning to attract attention, the broader technical picture suggests that any recovery attempts remain vulnerable unless key resistance is reclaimed.

Trendline Resistance Signals Short-Term Risk

On the short-term chart, analyst Kamran Asghar highlighted that ADA is facing descending trendline resistance, with bearish pressure building near the $0.35 area. His analysis suggests that repeated rejection from this trendline increases the likelihood of downside continuation if buyers fail to regain control.

Cardano’s ADA continues to face selling pressure near descending trendline resistance around $0.35, reinforcing short-term downside risk as lower highs persist. Source: Kamran Asghar via X

The chart shows ADA printing lower highs, a classic sign of weakening momentum. As long as price remains capped below the trendline, rallies risk being sold into rather than developing into sustained recoveries. In this context, rejection at current levels could expose ADA to renewed tests of lower support zones. This setup keeps short-term bias tilted towards caution, especially as broader market conditions remain mixed.

Cardano Daily Structure Remains Bearish

Further reinforcing the bearish outlook, data shared by CardanoMentor shows ADA trading well below its major daily moving averages. The chart reflects a prolonged downtrend, with price unable to reclaim the 50-day or 200-day averages, a condition typically associated with bearish continuation.

Momentum indicators on the daily timeframe remain weak, suggesting limited buying strength despite occasional relief bounces. As long as ADA remains below these averages, downside risk persists, and any upside attempts may struggle to gain momentum.

Cardano Price Prediction: ADA Faces Trendline Rejection Near alt=

ADA continues to trade below key daily moving averages, signaling sustained bearish structure and limited upside momentum. Source: CardanoMentor via X

Loss of Top-10 Market Cap Shows Weakness

Adding to the pressure, analyst Yazan pointed out that Cardano is no longer a top-10 cryptocurrency by market capitalization, a development that reflects prolonged underperformance relative to peers.

While market cap rankings alone do not determine future price direction, they often influence sentiment and capital rotation. ADA’s slide down the rankings underscores the lack of sustained demand and highlights the challenges facing the asset in regaining investor confidence in the short term. This sentiment backdrop aligns with the current technical weakness seen on the charts.

Loss of Top-10 Market Cap Shows Weakness

ADA slips out of the top-10 cryptocurrencies by market capitalization, highlighting prolonged underperformance and weak investor demand. Source: Yazan via X

Bulls Hopeful of Holding Weekly Support at $0.35-$0.30

On the higher timeframe, Cardano is trading inside a well-defined long-term support range between $0.30 and $0.35, a zone that has repeatedly acted as a demand base across multiple market cycles. This region coincides with prior consolidation from late 2020 and early 2023, making it technically significant rather than arbitrary.

Analyst Hardy highlighted this area as a structural accumulation zone, noting that price is currently compressing near the lower end of its multi-year range. His chart shows ADA repeatedly finding support above the $0.30 handle, suggesting that sellers are losing momentum as price revisits historically defended levels.

Bulls Hopeful of Holding Weekly Support at $0.35-$0.30

ADA compresses within a long-term support range between $0.30 and $0.35, an area analysts view as a potential accumulation zone if weekly support continues to hold. Source: Hardy via X

From a technical standpoint, a sustained hold above $0.30 keeps the broader base-building structure intact. A clean break below this level, however, would invalidate the accumulation thesis and expose ADA to deeper downside towards the $0.25 to $0.22 region, where the next major historical demand zone sits.

On the upside, the first meaningful sign of recovery would be a reclaim of the $0.38 to $0.40 resistance band, followed by acceptance above the $0.45 level.

Cardano Price Analysis

Cardano remains under pressure below trendline resistance near $0.35, keeping the short-term structure tilted bearish. Repeated rejections from this level suggest sellers are still in control, and as long as ADA Cardano price below this zone, upside attempts are likely to remain capped. On the downside, immediate support sits at $0.33 to $0.32, with a breakdown opening the door towards $0.30, a key psychological and technical level. A daily close below $0.30 would expose deeper downside risk towards $0.28 to $0.27.

For any recovery to gain momentum, ADA must reclaim $0.35 and then push above the $0.38 to $0.40 resistance band, which marks prior breakdown support and overhead supply. A sustained move above this region would improve momentum and shift focus towards $0.44–$0.46. Until those levels are reclaimed, price action remains corrective, with market watchers likely watching reactions around $0.33 and $0.30 for direction.

Final Thoughts: Is Cardano Near a Long-Term Base?

Cardano’s short-term outlook remains cautious, with bearish structure and resistance overhead continuing to cap price. Trendline rejection and weak momentum suggest that downside risks are still present in the near term.

However, longer-term charts are signaling a different story. The presence of a historically significant accumulation zone suggests that ADA may be transitioning from distribution into base-building. Whether this zone ultimately marks a durable bottom will depend on how Cardano price behaves here.



Source link

4 01, 2026

The truth about the ‘liquid gold’ supplement that claims to boost your immunity

By |2026-01-04T03:26:47+02:00January 4, 2026|Dietary Supplements News, News|0 Comments


Colostrum is often called “liquid gold” by lactation specialists, midwives and infant-health researchers. It’s the early milk produced in the first days after childbirth: thick, yellow and rich in antibodies, proteins and nutrients.

Newborn babies benefit greatly from it because their immune systems are not yet fully developed and their stomachs can only hold very small amounts. For babies, there’s no debate: colostrum is incredibly beneficial.

But some wellness brands are marketing colostrum to adults. Kourtney Kardashian Barker’s Lemme range sells it as sweet gummies, a sugar-free liquid supplement and creamer.

The appeal is easy to understand. Colostrum has a powerful reputation in infant health. If it protects newborns, many assume it must offer something extraordinary for adults too – but does it?

Babies and adults have very different nutritional needs. A newborn’s stomach holds only a few millilitres, and their immune system is immature. Colostrum provides highly concentrated immune and nutritional factors that the baby needs in its first days of life.

Kourtney Kardashian Barker’s Lemme range sells colostrum as sweet gummies, a sugar-free liquid supplement and creamer (Getty)

Adults, by contrast, have fully developed digestive and immune systems and can obtain nutrients from a varied diet. An adult stomach holds around one to one-and-a-half litres and expands further after eating. What is essential for a baby is not automatically useful or necessary for an adult body.

While colostrum has undeniable benefits in early life, the versions sold to adults are processed, flavoured and taken in much smaller amounts. That’s why it’s important to look closely at what these products contain and what their marketing suggests they can do.

Colostrum-based supplements are often promoted using persuasive wellness language and health-related suggestions, but scientific evidence for their effectiveness in adults remains limited, early and often based on small studies involving specific groups rather than healthy people. Here’s a closer look at the ideas behind some of these marketing messages and what research actually tells us.

Gut health, digestion and reduced bloating

Some small studies suggest that bovine colostrum might reduce temporary increases in intestinal permeability, sometimes called “leaky gut”, where the lining of the intestine becomes less effective at keeping out bacteria and toxins. These changes can occur after intense exercise or when taking non-steroidal anti-inflammatory medicines, drugs that can irritate the stomach and gut lining.

However, these studies involved only a small number of participants in specific contexts, not healthy adults in everyday life. The findings are considered preliminary and would require larger, well-designed clinical trials before any conclusions could be drawn about general digestive benefits.

The truth about the ‘liquid gold’ supplement that claims to boost your immunity

Some small studies suggest that bovine colostrum might reduce temporary increases in intestinal permeability (Getty/iStock)

The prebiotic fibres inulin and xylooligosaccharides, sometimes added to supplements, are much better studied. Inulin has been shown to increase levels of beneficial gut bacteria such as bifidobacteria, while xylooligosaccharides have been linked to greater bacterial diversity and small improvements in markers related to bowel health, obesity and type 2 diabetes in early research.

But these fibres are not unique to colostrum-based products. They also occur naturally in foods such as onions, garlic, leeks, bananas and chicory root and are widely available as standalone fibre supplements.

Immune system support

Colostrum helps newborns develop immunity by providing antibodies at a time when their immune systems are still forming. This does not mean that taking colostrum will strengthen a healthy adult’s immune system.

The idea of “boosting” immunity – a phrase used in promotional material for Kardashian Barker’s Lemme colostrum supplements – is common in wellness marketing, but it can be misleading.

A healthy immune system doesn’t usually need boosting, and an overactive one can cause harm by attacking the body’s own tissues, as happens in autoimmune conditions such as type 1 diabetes or rheumatoid arthritis.

About the author

Rachel Woods is a Senior Lecturer in Physiology at the University of Lincoln.

This article was first published by The Conversation and is republished under a Creative Commons licence. Read the original article.

Some research has explored the potential of bovine colostrum in specific conditions, such as ulcerative colitis and travellers’ diarrhoea. But these studies are small, focus on people who are already unwell and cannot be generalised to the wider population. Anyone with health concerns should seek medical advice before taking any supplement.

In Lemme’s products, references to immune support appear to rely primarily on vitamin D. Vitamin D does help regulate the immune system and supports bone health, and low levels are common in winter or in people with limited sunlight exposure. However, vitamin D is inexpensive and widely available as a standalone supplement.

“Full body wellness”

This is a broad phrase without a specific scientific definition. On the Lemme website, the company states that vitamin D supports healthy bones and teeth, which is accurate, but that benefit is not unique to its colostrum products.

“Glowing skin”

This phrase has appeared in some advertising coverage but not on the official product page. “Glowing skin” has no clinical definition and no standard method of measurement. There’s currently no evidence that colostrum, or any of the ingredients in these supplements, produces this effect.

How language influences trust

Lemme’s website includes the standard disclaimer found on most dietary supplements, stating that the products are not intended to diagnose, treat, cure or prevent disease.

The brand also describes its ingredients as “clinically studied.” This is not the same as “clinically proven.” The phrase typically means that an ingredient has been tested in some form of study, but it does not indicate whether the results were positive, significant or relevant to human health.

Research shows that consumers often confuse these terms. It sounds scientific, but does not demonstrate proven efficacy.

Colostrum is extraordinary for newborns. Nature designed it to protect babies during their most vulnerable days. For adults, however, there is no strong evidence from large, well-designed trials that colostrum supplements improve skin, digestion or immunity in healthy individuals. Some ingredients in these products may show potential in specific medical conditions, but that is not the same as demonstrating general wellness effects.

Colostrum supplements primarily market the idea of something pure, powerful and natural. At present, the science does not fully support these suggestions.



Source link

4 01, 2026

Solana Price Prediction: Solana Holds $120 Support as Momentum Hints at a Trend Reversal

By |2026-01-04T03:18:35+02:00January 4, 2026|Crypto News, News|0 Comments

Solana price is consolidating above key support levels as price tightens, with traders watching closely for signs of a potential upside breakout.

Solana price has been moving sideways for a while now, but the range is starting to tighten. Price is holding above key support, yet every push higher keeps getting sold. With momentum cooling and the chart compressing, Solana Price Prediction is back in focus as market watchers wait to see which side finally takes control.

Short-Term Structure Remains Capped Below Descending Channel Resistance

On the daily timeframe, Solana is attempting to break past the descending channel, a structure that has defined price action since the post-ATH correction. However, according to Nehal, as long as SOL remains below the upper channel resistance near $155–$160, upside moves should still be treated as corrective rather than impulsive.

Solana price trades below descending channel resistance near $155–$160, keeping the short-term structure capped despite repeated support holds. Source: Nehal via X

Repeated rejections from this zone reinforce it as the key level bulls must reclaim to signal a shift in trend. Failure to break above this area keeps downside risk active towards the $120–$115 support region, which has acted as a short-term demand zone during recent pullbacks. A daily close above $160 would be the first structural sign that sellers are losing control.

RSI and Momentum Echo Historical Oversold Conditions

Momentum indicators provide important context to the current consolidation. Immortal highlighted that during Solana’s capitulation low near $8, RSI printed around 28, marking extreme oversold conditions. In the most recent pullback, RSI once again dipped close to 30, suggesting selling pressure may be nearing exhaustion rather than accelerating.

Solana Price Prediction: Solana Holds 0 Support as Momentum Hints at a Trend Reversal

Solana’s RSI drops back toward the 30 level, mirroring historically oversold conditions that previously marked selling exhaustion. Source: Immortal via X

Adding to this, That’s My Quant noted that Solana has been consolidating for over a year, with RSI spending extended time near historically undervalued zones. This behavior typically aligns more with accumulation phases than with early-stage bear market expansions, though confirmation is still required through price.

RSI and Momentum Echo Historical Oversold Conditions

Solana continues a year-long consolidation, with RSI lingering near historically undervalued zones that often align with accumulation phases. Source: That’s My Quant via X

Weekly Support Zone Keeps Long-Term Bulls Engaged

Zooming out to the higher timeframe, Solana price is currently holding a major weekly support band between $110 and $125, an area that previously acted as a base before large upside expansions. Long-term participants are closely watching this zone, as sustained acceptance above it keeps the broader structure neutral-to-constructive rather than decisively bearish.

From a market structure perspective, as long as SOL does not lose the $110 weekly support, the probability of continued range development remains higher than that of a full trend breakdown. However, reclaiming $160, followed by a move through the $180–$200 resistance cluster, would be necessary to re-establish a bullish higher-high sequence.

On-Chain Strength Adds a Contrasting Narrative

While price remains technically constrained, on-chain data paints a more constructive outlook. Crypto Chiefs highlighted that Solana currently leads application revenue among major chains, capturing a significant share relative to Ethereum and others. This divergence between on-chain strength and price action often appears during late consolidation phases, though timing remains uncertain.

On-Chain Strength Adds a Contrasting Narrative

Solana leads application revenue among major blockchains, highlighting strong on-chain activity despite price remaining range-bound. Source: Crypto Chiefs via X

Technical Structure Shaping Solana’s Next Move

Several technical signals are defining Solana’s current consolidation phase. On the daily chart, Solana price is trading within a descending channel, with price repeatedly forming higher lows near the lower boundary, suggesting selling pressure is slowing.

Technical Structure Shaping Solana’s Next Move

Solana current price is $132.73, up 5.42% in the last 24 hours. Source: Brave New Coin

This compression indicates a market waiting for direction rather than trending impulsively.

Key levels to watch:

  • Channel resistance: $155–$160
  • Near-term upside zone: $180–$200 if a daily close above $160 holds
  • Primary support: $120–$115
  • Major weekly support: $110–$125

The structure remains neutral-to-bullish as long as SOL holds above weekly support. A clean breakout above the upper channel, ideally accompanied by rising volume, would signal a shift from corrective price action into trend recovery. Until then, rallies remain vulnerable to rejection, keeping SOL range-bound.

Momentum indicators such as RSI hovering near historically oversold zones further reinforce the idea that this is a compression and basing phase, not a momentum-driven breakdown.

Final Thoughts: Can Solana Price Reclaim Bullish Momentum?

Solana price is not in a confirmed uptrend yet, but it is also not breaking down. The market is compressing between weekly support at $110 to $125 and channel resistance at $155–$160, with momentum indicators suggesting downside pressure is slowing rather than accelerating.

A clean daily and weekly reclaim above $160 would significantly improve the bullish case and open Solana price prediction towards $180 to $200. Until then, SOL remains in a technically neutral consolidation phase, where patience and confirmation matter more than anticipation.



Source link

Go to Top